The Alzheimer's Drug Discovery Foundation and The Michael J. Fox Foundation Launch $5 Million Partnership to Target Key Co-Pathologies Driving Alzheimer's and Parkinson's

Summary

The Alzheimer's Drug Discovery Foundation and The Michael J. Fox Foundation launched a $5 million partnership to accelerate development of scalable, minimally invasive biomarkers targeting co-pathologies in Alzheimer's and Parkinson's diseases.